Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Description
Keywords
COV-BOOST study group
Is Part Of
Publisher
Elsevier BV